Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Hepatocellular Carcinoma (HCC) × brivanib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 5 Colorectal Neoplasms 3 Liver Neoplasms 2 Sarcoma 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced Hepatocellular Carcinoma (HCC) 1 Adenocarcinoma Of Esophagus 1 Acrocephalosyndactylia 1

Interventions

brivanib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04212221 2024-07-23

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Zai Lab (Hong Kong), Ltd.

Phase 1/2 Terminated

89 enrolled 23 charts

Gastrointestinal

Advanced Hepatocellular Carcinoma (HCC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡